The Triangle of Death in Alzheimer's Disease Brain: The Aberrant Cross-Talk Among Energy Metabolism, Mammalian Target of Rapamycin Signaling, and Protein Homeostasis Revealed by Redox Proteomics.
Alzheimer's disease (AD) is a multifactorial neurodegenerative disorder and represents one of the most disabling conditions. AD shares many features in common with systemic insulin resistance diseases, suggesting that it can be considered as a metabolic disease, characterized by reduced insulin-stimulated growth and survival signaling, increased oxidative stress (OS), proinflammatory cytokine activation, mitochondrial dysfunction, impaired energy metabolism, and altered protein homeostasis. Recent Advances: Reduced glucose utilization and energy metabolism in AD have been associated with the buildup of amyloid-β peptide and hyperphosphorylated tau, increased OS, and the accumulation of unfolded/misfolded proteins. Mammalian target of rapamycin (mTOR), which is aberrantly activated in AD since early stages, plays a key role during AD neurodegeneration by, on one side, inhibiting insulin signaling as a negative feedback mechanism and, on the other side, regulating protein homeostasis (synthesis/clearance).



It is likely that the concomitant and mutual alterations of energy metabolism-mTOR signaling-protein homeostasis might represent a self-sustaining triangle of harmful events that trigger the degeneration and death of neurons and the development and progression of AD. Intriguingly, the altered cross-talk between the components of such a triangle of death, beyond altering the redox homeostasis of the neuron, is further exacerbated by increased levels of OS that target and impair key components of the pathways involved. Redox proteomic studies in human samples and animal models of AD-like dementia led to identification of oxidatively modified components of the pathways composing the triangle of death, therefore revealing the crucial role of OS in fueling this aberrant vicious cycle.



The identification of compounds able to restore the function of the pathways targeted by oxidative damage might represent a valuable therapeutic approach to slow or delay AD. Antioxid. Redox Signal. 26, 364-387.
1 Department of Biochemical Sciences, Sapienza University of Rome , Rome, Italy .
Fabio
F
Di Domenico
1 Department of Biochemical Sciences, Sapienza University of Rome , Rome, Italy .|2 Facultad de Salud, Instituto de Ciencias Biomédicas, Universidad Autónoma de Chile , Santiago, Chile .
Eugenio
E
Barone
1 Department of Biochemical Sciences, Sapienza University of Rome , Rome, Italy .
Marzia
M
Perluigi
3 Department of Chemistry, Sanders-Brown Center of Aging, University of Kentucky , Lexington, Kentucky.
D Allan
DA
Butterfield
D000544:Alzheimer Disease / Q000209:etiology / Q000378:metabolism*; D000818:Animals; D001343:Autophagy; D001921:Brain / Q000378:metabolism*; D016022:Case-Control Studies; D004734:Energy Metabolism; D006706:Homeostasis; D006801:Humans; D007328:Insulin / Q000378:metabolism; D009474:Neurons / Q000378:metabolism / Q000473:pathology; D010084:Oxidation-Reduction; D018384:Oxidative Stress; D046988:Proteasome Endopeptidase Complex / Q000378:metabolism; D040901:Proteomics / Q000379:methods; D015398:Signal Transduction; D058570:TOR Serine-Threonine Kinases / Q000378:metabolism*; D025801:Ubiquitin / Q000378:metabolism; D056811:Unfolded Protein Response
D007328:Insulin; D025801:Ubiquitin; D058570:TOR Serine-Threonine Kinases; D046988:Proteasome Endopeptidase Complex
Alzheimer disease; energy metabolism; mTOR; protein degradation